Theranostic medicine combines diagnostics and therapeutics, focusing on solid tumors at
minimal doses. Optically activated photosensitizers are significant examples owing to their …

Peritoneal carcinomatosis (PC) is caused by metastasis of primary tumor cells from intra-
abdominal organs to the peritoneal surface. Intraperitoneal (IP) chemotherapy allows close …

Simple Summary Recent advances in molecular medicine have indicated G-protein coupled
receptors (GPCRs) as possible therapeutic targets in ovarian cancer. The cellular effects of …

Ovarian cancer, ranking as the seventh most prevalent malignancy among women globally,
faces significant challenges in diagnosis and therapeutic intervention. The difficulties in …

Genetic heterogeneity in ovarian cancer indicates the need for personalised treatment
approaches. Currently, very few G-protein coupled receptors (GPCRs) have been …

Ovarian cancers are a complex and heterogenic group of malignancies that are difficult to
detect, diagnose and treat. Fortunately, considerable knowledge of ovarian cancer specific …

The number of publications on nanomedicine in oncology has been exponential over the
last ten years, going from 640 publications in 2012 to 2487 publications in 2022, reflecting …

Abstract Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine/hormonal disorder
affecting women of reproductive age worldwide. It is characterized by hormonal imbalances …

With the advent of targeted therapies came a new paradigm for cancer treatment. The
specific interaction between ligands and surface receptors has been exploited to increase …

CONCLUSION The use of immunological methods to treat human medical disorders has
been in existence for a number of centuries. In the last 30 years, two major advances have …